Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

LGC licenses first DNA test for response to schizophrenia treatment from the Institute of Psychiatry, King’s College London

09.11.2005


LGC, Europe’s leading independent analytical laboratory providing advanced chemical, biochemical and forensic analysis, has announced an exclusive agreement with King’s College London to offer the first pharmacogenetic screening service which will predict whether a patient with schizophrenia will respond positively to the antipsychotic drug clozapine. Developed following 13 years of research by Professor Robert Kerwin and Dr Maria Arranz from the Institute of Psychiatry at King’s, the test will help clinicians tailor the management of medication for schizophrenia to the needs of the patient.



Schizophrenia is considered the most chronic, debilitating and costly mental illness and affects between 1-2% of all populations. There is no permanent cure, but symptoms of the illness can be controlled by antipsychotic drugs. However, not all patients benefit from treatment and up to 40% of patients do not show a complete response - this is known as Treatment Resistant Schizophrenia (TRS).

Although clozapine is the only licensed drug with proven efficiency in the treatment of TRS its treatment can cause potentially serious side effects. It is therefore commonly only prescribed to patients when other medicines have failed. On average patients currently progress through four different antipsychotic medications over a period of five years before being treated with clozapine.


The test, which will be available to the clinical community from early January 2006, is a test based on a panel of single nucleotide polymorphisms (SNPs) that will be analysed using LGC’s proprietary fluorescent HyBeacons DNA probe technology. Dr Paul Debenham, Director of Life Sciences at LGC, said: "This new prediction test of treatment response to clozapine should prove to be an extremely valuable tool for clinicians, aiding them in their prescribing choice of antipsychotic drug for their patients. It will mean that clozapine can be prescribed much earlier on in the treatment of patients who are predicted to be responsive to the drug, thus reducing the suffering time of the patient and the associated cost of care. We are therefore delighted to be in a position to offer this kind of screening service to clinicians for the first time. This agreement is also great news for LGC, enabling us to build on our recent status as the first independent laboratory to become a member of the NHS Genetic Testing Network."

King’s Professor Robert Kerwin said: "This agreement follows 13 years of research at IoP into treatment for schizophrenia, working with more than 200 patients treated with clozapine. We are therefore delighted to be sharing the results of our research and to be working with LGC to be able to bring a viable example of personalised medicine into fruition."

Dr Paul Debenham and Professor Kerwin will be giving a presentation to discuss this new screening service at the ’Good Practice in Biological Investigation’ conference at Institute of Psychiatry, Denmark Hill campus, King’s College London, on Tuesday 8 November 2005. genetic services.

Wendy Taylor | alfa
Further information:
http://www.lgc.co.uk

More articles from Health and Medicine:

nachricht New vaccine production could improve flu shot accuracy
25.07.2017 | Duke University

nachricht Chances to treat childhood dementia
24.07.2017 | Julius-Maximilians-Universität Würzburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Carbon Nanotubes Turn Electrical Current into Light-emitting Quasi-particles

Strong light-matter coupling in these semiconducting tubes may hold the key to electrically pumped lasers

Light-matter quasi-particles can be generated electrically in semiconducting carbon nanotubes. Material scientists and physicists from Heidelberg University...

Im Focus: Flexible proximity sensor creates smart surfaces

Fraunhofer IPA has developed a proximity sensor made from silicone and carbon nanotubes (CNT) which detects objects and determines their position. The materials and printing process used mean that the sensor is extremely flexible, economical and can be used for large surfaces. Industry and research partners can use and further develop this innovation straight away.

At first glance, the proximity sensor appears to be nothing special: a thin, elastic layer of silicone onto which black square surfaces are printed, but these...

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA mission surfs through waves in space to understand space weather

25.07.2017 | Physics and Astronomy

Strength of tectonic plates may explain shape of the Tibetan Plateau, study finds

25.07.2017 | Earth Sciences

The dense vessel network regulates formation of thrombocytes in the bone marrow

25.07.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>